Shares of Cantel Medical (CMN +0.9%) rise a day after the company reported Q3 results that met expectations. Piper Jaffray (Overweight) analyst Thomas Gunderson says CMN has "a strong management team that … can keep EPS growing with further acquisitions, higher margin new products, and tight expense controls." Price target raised to $40 from $35.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs